Clinical Trial Update: Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the effect of platelet inhibition and/or lipid lowering in non-ACS patients with positive troponin was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chest Syndrome

Snippet

Sponsor: Dr. med. Mahir Karakas | Conditions: Acute Chest Syndrome | Phase 3 | Status: TERMINATED